FindTrial
Sign In

Measurable Residual Disease Detection by Next-generation Sequencing of T Cell Receptor Gene Rearrangements in Pediatric T-cell Acute Lymphocytic Leukemia

Measurable Residual Disease Detection by Next-generation Sequencing of T Cell Receptor Gene Rearrangements in Pediatric T-cell Acute Lymphocytic Leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091477
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute T cell lymphoblastic leukemia

Interventions

Case series:NA

Sponsors

Children's Hospital,Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1.T-ALL patients with NGS-MRD;

Exclusion criteria

Exclusion criteria: 1.Patients without NGS-MRD;

Design outcomes

Primary

MeasureTime frame
EFS;Overall survival;—

Countries

China

Contacts

Public ContactChan Liao

Children's Hospital,Zhejiang University School of Medicine

liaochan@zju.edu.cn+86 571 88873450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026